Masao Ota - Search Results

Year	Number of Results
2002	8
2003	10
2004	2
2005	6
2006	13
2007	11
2008	12
2009	13
2010	13
2011	14
2012	12
2013	7
2014	6
2015	7
2016	8
2017	11
2018	9
2019	2
2020	7
2021	5
2022	1

1

Immunogenetics of IgG4-Related AIP.

Ota M, Umemura T, Kawa S. Ota M, et al. Curr Top Microbiol Immunol. 2017;401:35-44. doi: 10.1007/82_2016_37. Curr Top Microbiol Immunol. 2017. PMID: 27832379 Review.

2

Genetics and epigenetics in the pathogenesis of primary biliary cholangitis.

Joshita S, Umemura T, Tanaka E, Ota M. Joshita S, et al. Among authors: ota m. Clin J Gastroenterol. 2018 Feb;11(1):11-18. doi: 10.1007/s12328-017-0799-z. Epub 2017 Nov 20. Clin J Gastroenterol. 2018. PMID: 29159718 Review.

3

Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis.

Joshita S, Umemura T, Tanaka E, Ota M. Joshita S, et al. Among authors: ota m. J Immunol Res. 2017;2017:3073504. doi: 10.1155/2017/3073504. Epub 2017 Feb 1. J Immunol Res. 2017. PMID: 28255561 Free PMC article. Review.

4

Does the interaction of KIR and HLA affect the development of non-infectious uveitis?

Nakamura J, Takeuchi M, Ota M, Mizuki N, Ohno S. Nakamura J, et al. Among authors: ota m. Curr Mol Med. 2021 Oct 26. doi: 10.2174/1566524021666211027092124. Online ahead of print. Curr Mol Med. 2021. PMID: 34711163

5

The association analysis between HLA-A*26 and Behçet's disease.

Nakamura J, Meguro A, Ishii G, Mihara T, Takeuchi M, Mizuki Y, Yuda K, Yamane T, Kawagoe T, Ota M, Mizuki N. Nakamura J, et al. Among authors: ota m. Sci Rep. 2019 Mar 14;9(1):4426. doi: 10.1038/s41598-019-40824-y. Sci Rep. 2019. PMID: 30872678 Free PMC article.

6

Genetic factors affect the etiology, clinical characteristics and outcome of autoimmune hepatitis.

Umemura T, Ota M. Umemura T, et al. Among authors: ota m. Clin J Gastroenterol. 2015 Dec;8(6):360-6. doi: 10.1007/s12328-015-0620-9. Epub 2015 Dec 10. Clin J Gastroenterol. 2015. PMID: 26661115 Review.

7

Quantitative and qualitative lipid improvement with chronic hepatitis C virus eradication using direct-acting antivirals.

Joshita S, Yamashita Y, Okamoto T, Usami Y, Sugiura A, Yamazaki T, Kakino A, Ota M, Sawamura T, Umemura T. Joshita S, et al. Among authors: ota m. Hepatol Res. 2021 Jul;51(7):758-766. doi: 10.1111/hepr.13666. Epub 2021 May 26. Hepatol Res. 2021. PMID: 33982310

8

Investigation of the Effect of KIR-HLA Pairs on Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients.

Umemura T, Joshita S, Saito H, Wakabayashi SI, Kobayashi H, Yamashita Y, Sugiura A, Yamazaki T, Ota M. Umemura T, et al. Among authors: ota m. Cancers (Basel). 2021 Jun 29;13(13):3267. doi: 10.3390/cancers13133267. Cancers (Basel). 2021. PMID: 34209910 Free PMC article.

9

Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients.

Joshita S, Ota M, Kobayashi H, Wakabayashi SI, Yamashita Y, Sugiura A, Yamazaki T, Tanaka E, Umemura T. Joshita S, et al. Among authors: ota m. Sci Rep. 2021 Nov 2;11(1):21424. doi: 10.1038/s41598-021-01014-x. Sci Rep. 2021. PMID: 34728722 Free PMC article.

10

Protocol: Prospective observational study aiming for micro-elimination of hepatitis C virus in Nagawa town: The Nagawa Project.

Kobayashi H, Joshita S, Akahane Y, Matsuzaki K, Yamada H, Aomura D, Joshita N, Midorikawa H, Suyama K, Ota M, Wakabayashi SI, Yamashita Y, Sugiura A, Yamazaki T, Misawa H, Umemura T. Kobayashi H, et al. Among authors: ota m. PLoS One. 2021 Aug 26;16(8):e0256711. doi: 10.1371/journal.pone.0256711. eCollection 2021. PLoS One. 2021. PMID: 34437651 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results